Vericel Corporation Company Profile (NASDAQ:VCEL)

About Vericel Corporation (NASDAQ:VCEL)

Vericel Corporation logoVericel Corporation, formerly Aastrom Biosciences, Inc., is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. The Company operates through the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases segment. Its autologous cell therapy products include Carticel (autologous cultured chondrocytes), which is an autologous chondrocyte implant for the treatment of cartilage defects in the knee, and Epicel (cultured epidermal autografts), which is a permanent skin replacement for the treatment of patients with deep-dermal or full-thickness burns. The Company is developing MACI, which is a third-generation autologous chondrocyte implant and ixmyelocel-T, which is a patient-specific multicellular therapy.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biopharmaceuticals
  • Sub-Industry: N/A
  • Symbol: NASDAQ:VCEL
  • CUSIP: N/A
  • Web: www.aastrom.com
Capitalization:
  • Market Cap: $162.48 million
  • Outstanding Shares: 32,824,000
Average Prices:
  • 50 Day Moving Avg: $3.81
  • 200 Day Moving Avg: $3.11
  • 52 Week Range: $2.00 - $5.25
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -13.38
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $53.77 million
  • Price / Sales: 3.02
  • Book Value: $0.43 per share
  • Price / Book: 11.51
Profitability:
  • EBIDTA: ($20,030,000.00)
  • Net Margins: -50.27%
  • Return on Assets: -59.46%
Debt:
  • Debt-to-Equity Ratio: 0.58%
  • Current Ratio: 2.55%
  • Quick Ratio: 2.31%
Misc:
  • Average Volume: 519,542 shs.
  • Beta: 3.07
  • Short Ratio: 5.26
 

Frequently Asked Questions for Vericel Corporation (NASDAQ:VCEL)

What is Vericel Corporation's stock symbol?

Vericel Corporation trades on the NASDAQ under the ticker symbol "VCEL."

How were Vericel Corporation's earnings last quarter?

Vericel Corporation (NASDAQ:VCEL) issued its earnings results on Wednesday, August, 9th. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.24) by $0.16. The firm earned $16.95 million during the quarter. View Vericel Corporation's Earnings History.

When will Vericel Corporation make its next earnings announcement?

Vericel Corporation is scheduled to release their next quarterly earnings announcement on Monday, November, 6th 2017. View Earnings Estimates for Vericel Corporation.

Where is Vericel Corporation's stock going? Where will Vericel Corporation's stock price be in 2017?

3 brokers have issued 12-month price objectives for Vericel Corporation's stock. Their forecasts range from $6.00 to $7.00. On average, they anticipate Vericel Corporation's stock price to reach $6.33 in the next twelve months. View Analyst Ratings for Vericel Corporation.

Who are some of Vericel Corporation's key competitors?

Who are Vericel Corporation's key executives?

Vericel Corporation's management team includes the folowing people:

  • Robert L. Zerbe M.D., Independent Chairman of the Board
  • Dominick C. Colangelo, President, Chief Executive Officer, Director
  • Gerard J. Michel, Chief Financial Officer, Vice President - Corporate Development
  • Daniel R. Orlando, Chief Operating Officer, Chief Commercial Officer
  • Ross Tubo, Chief Scientific Officer
  • David Recker M.D., Chief Medical Officer
  • Steven C. Gilman Ph.D., Director
  • Heidi Hagen, Director
  • Kevin F. McLaughlin, Director
  • Paul Kevin Wotton Ph.D., Director

Who owns Vericel Corporation stock?

Vericel Corporation's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Stonepine Capital Management LLC (9.10%), Archon Capital Management LLC (4.08%), Vanguard Group Inc. (3.70%), First Washington CORP (2.06%), Perkins Capital Management Inc. (0.79%) and Northern Trust Corp (0.19%). View Institutional Ownership Trends for Vericel Corporation.

Who sold Vericel Corporation stock? Who is selling Vericel Corporation stock?

Vericel Corporation's stock was sold by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC and Kopp Investment Advisors LLC. View Insider Buying and Selling for Vericel Corporation.

Who bought Vericel Corporation stock? Who is buying Vericel Corporation stock?

Vericel Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Archon Capital Management LLC, First Washington CORP, Vanguard Group Inc., Perkins Capital Management Inc., Bank of New York Mellon Corp and Northern Trust Corp. View Insider Buying and Selling for Vericel Corporation.

How do I buy Vericel Corporation stock?

Shares of Vericel Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vericel Corporation's stock price today?

One share of Vericel Corporation stock can currently be purchased for approximately $4.95.


MarketBeat Community Rating for Vericel Corporation (NASDAQ VCEL)
Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  110 (Vote Outperform)
Underperform Votes:  78 (Vote Underperform)
Total Votes:  188
MarketBeat's community ratings are surveys of what our community members think about Vericel Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Vericel Corporation (NASDAQ:VCEL) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.33 (27.95% upside)

Analysts' Ratings History for Vericel Corporation (NASDAQ:VCEL)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/7/2017BTIG ResearchReiterated RatingBuy$6.00MediumView Rating Details
8/10/2017Piper Jaffray CompaniesReiterated RatingBuy$7.00HighView Rating Details
3/13/2017Needham & Company LLCReiterated RatingBuy -> Buy$9.00 -> $6.00HighView Rating Details
4/5/2016Bank of America CorporationDowngradeBuy -> NeutralN/AView Rating Details
3/12/2016Ladenburg Thalmann Financial ServicesReiterated RatingBuyN/AView Rating Details
(Data available from 9/21/2015 forward)

Earnings

Earnings History for Vericel Corporation (NASDAQ:VCEL)
Earnings by Quarter for Vericel Corporation (NASDAQ:VCEL)
Earnings History by Quarter for Vericel Corporation (NASDAQ VCEL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017($0.16)N/AView Earnings Details
8/9/2017Q2 2017($0.24)($0.08)$16.95 millionViewListenView Earnings Details
5/10/2017Q1 2017($0.19)($0.31)$9.36 millionViewN/AView Earnings Details
11/7/2016Q3($0.28)($0.38)$10.93 millionViewListenView Earnings Details
5/10/2016Q116($0.25)($0.08)$11.60 million$14.10 millionViewListenView Earnings Details
3/14/2016Q415($0.15)($0.28)$17.36 million$15.40 millionViewListenView Earnings Details
11/13/2015Q315($0.21)($0.26)$10.50 million$11.30 millionViewListenView Earnings Details
8/12/2015Q215($0.13)($0.16)$11.31 million$13.60 millionViewListenView Earnings Details
5/14/2015Q115($0.14)($0.27)$11.10 million$10.80 millionViewListenView Earnings Details
3/23/2015Q414($0.47)($0.17)$10.70 million$14.70 millionViewListenView Earnings Details
11/13/2014Q314($0.66)($0.52)$6.73 million$9.66 millionViewN/AView Earnings Details
8/14/2014Q214($1.59)($0.94)$2.50 million$4.43 millionViewN/AView Earnings Details
5/15/2014Q114($0.92)($1.26)ViewN/AView Earnings Details
3/13/2014Q413($1.34)($0.97)$0.02 million$0.01 millionViewN/AView Earnings Details
11/12/2013Q3($2.02)($0.06)ViewListenView Earnings Details
5/8/2013Q1 2013($0.19)($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Vericel Corporation (NASDAQ:VCEL)
Current Year EPS Consensus Estimate: $-0.63 EPS
Next Year EPS Consensus Estimate: $-0.37 EPS

Dividends

Dividend History for Vericel Corporation (NASDAQ:VCEL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Vericel Corporation (NASDAQ:VCEL)
Insider Ownership Percentage: 3.30%
Institutional Ownership Percentage: 33.84%
Insider Trades by Quarter for Vericel Corporation (NASDAQ:VCEL)
Institutional Ownership by Quarter for Vericel Corporation (NASDAQ:VCEL)
Insider Trades by Quarter for Vericel Corporation (NASDAQ:VCEL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/28/2016Consonance Capital ManagementMajor ShareholderSell120,000$5.39$646,800.00View SEC Filing  
9/16/2014Daniel OrlandoCOOBuy9,804$2.55$25,000.20View SEC Filing  
9/16/2014Dominick ColangeloCEOBuy20,000$2.55$51,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Vericel Corporation (NASDAQ:VCEL)
Latest Headlines for Vericel Corporation (NASDAQ:VCEL)
Source:
DateHeadline
finance.yahoo.com logoVericel to Present at the Ladenburg Thalmann 2017 Healthcare Conference
finance.yahoo.com - September 20 at 10:48 AM
americanbankingnews.com logoVericel Corporation (VCEL) & its Peers Financial Comparison
www.americanbankingnews.com - September 11 at 1:06 PM
americanbankingnews.com logoVericel Corporation (VCEL) Receives "Buy" Rating from BTIG Research
www.americanbankingnews.com - September 7 at 10:34 AM
americanbankingnews.com logoVericel Corporation (VCEL) Expected to Announce Earnings of -$0.21 Per Share
www.americanbankingnews.com - August 11 at 2:36 PM
seekingalpha.com logoVericel's (VCEL) CEO Nick Colangelo on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 10 at 9:19 AM
finance.yahoo.com logoEdited Transcript of VCEL earnings conference call or presentation 9-Aug-17 12:00pm GMT
finance.yahoo.com - August 10 at 9:19 AM
americanbankingnews.com logoVericel Corporation (NASDAQ:VCEL) Announces Earnings Results
www.americanbankingnews.com - August 9 at 3:03 PM
finance.yahoo.com logoVericel Reports Second-Quarter 2017 Financial Results
finance.yahoo.com - August 9 at 8:54 AM
americanbankingnews.com logoVericel Corporation (NASDAQ:VCEL) Scheduled to Post Earnings on Wednesday
www.americanbankingnews.com - August 2 at 7:10 AM
globenewswire.com logoVericel to Host Second-Quarter 2017 Earnings Webcast and Conference Call on August 9, 2017 - GlobeNewswire (press release)
globenewswire.com - July 26 at 9:38 AM
globenewswire.com logoVericel to Host Second-Quarter 2017 Earnings Webcast and Conference Call on August 9, 2017 - GlobeNewswire (press release)
globenewswire.com - July 26 at 9:38 AM
finance.yahoo.com logoVericel to Host Second-Quarter 2017 Earnings Webcast and Conference Call on August 9, 2017
finance.yahoo.com - July 26 at 9:38 AM
finance.yahoo.com logoVericel to Host Second-Quarter 2017 Earnings Webcast and Conference Call on August 9, 2017
finance.yahoo.com - July 26 at 9:38 AM
americanbankingnews.com logoVericel Corporation (NASDAQ:VCEL) Expected to Announce Earnings of -$0.24 Per Share
www.americanbankingnews.com - July 22 at 12:08 AM
nasdaq.com logoVericel to Host Symposium on MACI Implant for Treating Articular ... - Nasdaq
www.nasdaq.com - July 13 at 11:06 AM
finance.yahoo.com logoVericel to Host Symposium on MACI Implant for Treating Articular Cartilage Defects in the Knee at AOSSM 2017 Annual Meeting
finance.yahoo.com - July 13 at 11:06 AM
finance.yahoo.com logoETFs with exposure to Vericel Corp. : July 7, 2017
finance.yahoo.com - July 8 at 4:01 PM
americanbankingnews.com logoAnalyzing Horizon Therapeutics (HPTX) & Vericel Corporation (VCEL)
www.americanbankingnews.com - July 2 at 6:26 PM
americanbankingnews.com logoZacks: Brokerages Anticipate Vericel Corporation (VCEL) to Announce -$0.24 EPS
www.americanbankingnews.com - June 27 at 8:10 PM
finance.yahoo.com logoETFs with exposure to Vericel Corp. : June 26, 2017
finance.yahoo.com - June 26 at 8:26 PM
seekingalpha.com logoWeek 26 Breakout Forecast Short-Term Picks To Give You An Edge
seekingalpha.com - June 25 at 7:17 AM
streetinsider.com logoUPDATE: BTIG Starts Vericel Corporation (VCEL) at Buy - StreetInsider.com
www.streetinsider.com - June 22 at 2:30 PM
americanbankingnews.com logoVericel Corporation (VCEL) Coverage Initiated at BTIG Research
www.americanbankingnews.com - June 20 at 5:30 PM
finance.yahoo.com logoETFs with exposure to Vericel Corp. : June 16, 2017
finance.yahoo.com - June 17 at 7:02 AM
finance.yahoo.com logoVericel Corp. :VCEL-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017
finance.yahoo.com - June 15 at 3:37 AM
americanbankingnews.com logo-$0.24 Earnings Per Share Expected for Vericel Corp (VCEL) This Quarter
www.americanbankingnews.com - June 1 at 6:30 PM
finance.yahoo.com logoEdited Transcript of VCEL earnings conference call or presentation 10-May-17 12:00pm GMT
finance.yahoo.com - May 12 at 3:44 AM
americanbankingnews.com logoVericel Corp (VCEL) Releases Quarterly Earnings Results, Misses Estimates By $0.12 EPS
www.americanbankingnews.com - May 11 at 4:26 PM
seekingalpha.com logoVericel's (VCEL) CEO Nick Colangelo on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 3:03 AM
finance.yahoo.com logoVericel Licenses Product Portfolio to Innovative Cellular Therapeutics for Distribution in China, South Korea, and other Countries in Southeast Asia
finance.yahoo.com - May 10 at 10:00 AM
finance.yahoo.com logoVericel Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Ixmyelocel-T for the Treatment of Advanced Heart Failure Due to Ischemic Dilated Cardiomyopathy
finance.yahoo.com - May 10 at 10:00 AM
finance.yahoo.com logoVericel Reports First-Quarter 2017 Financial Results
finance.yahoo.com - May 10 at 10:00 AM
finance.yahoo.com logoInvestor Network: Vericel Corporation to Host Earnings Call
finance.yahoo.com - May 10 at 10:00 AM
americanbankingnews.com logoVericel Corp (VCEL) Expected to Announce Earnings of -$0.19 Per Share
www.americanbankingnews.com - May 8 at 1:12 PM
americanbankingnews.com logoVericel Corp (VCEL) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - May 6 at 7:04 AM
finance.yahoo.com logoVericel to Host First-Quarter 2017 Earnings Webcast and Conference Call on May 10, 2017
finance.yahoo.com - May 5 at 3:10 AM
americanbankingnews.com logoVericel Corp (VCEL) Getting Somewhat Negative Press Coverage, Report Shows
www.americanbankingnews.com - April 30 at 9:04 AM
americanbankingnews.com logoShort Interest in Vericel Corp (VCEL) Drops By 4.7%
www.americanbankingnews.com - April 29 at 7:18 PM
globenewswire.com logoVericel to Present at the 5th Annual Cell & Gene Therapy Investor Day - GlobeNewswire (press release)
globenewswire.com - April 21 at 8:30 PM
americanbankingnews.com logo Analysts Anticipate Vericel Corp (VCEL) to Post -$0.19 Earnings Per Share
www.americanbankingnews.com - April 17 at 3:06 PM
finance.yahoo.com logoVericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
finance.yahoo.com - April 10 at 8:00 PM
finance.yahoo.com logoETFs with exposure to Vericel Corp. : April 7, 2017
finance.yahoo.com - April 7 at 6:21 PM
finance.yahoo.com logoVericel to Present at the 16th Annual Needham Healthcare Conference
finance.yahoo.com - March 28 at 8:29 AM
us.rd.yahoo.com logoOutcomes Data From Over 950 Severe Burn Patients Treated With Epicel Presented at the 49th Annual Meeting of the American Burn Association
us.rd.yahoo.com - March 23 at 3:50 PM
americanbankingnews.com logoVericel Corp’s (VCEL) “Buy” Rating Reiterated at Needham & Company LLC
www.americanbankingnews.com - March 17 at 9:29 AM
baystreet.ca logoVericel Corp (VCEL) Gains Despite Projected Loss
www.baystreet.ca - March 11 at 11:33 PM
seekingalpha.com logoVericel's (VCEL) CEO Nick Colangelo on Q4 2016 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 11 at 9:58 AM
us.rd.yahoo.com logoVericel Reports Fourth-Quarter and Year-End 2016 Financial Results
us.rd.yahoo.com - March 10 at 10:08 AM
biz.yahoo.com logoVERICEL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - March 10 at 10:08 AM
seekingalpha.com logoVericel (VCEL) Presents At Cowen and Company 37th Annual Health Care Conference - Slideshow
seekingalpha.com - March 9 at 4:10 AM

Social

Chart

Vericel Corporation (VCEL) Chart for Thursday, September, 21, 2017

This page was last updated on 9/21/2017 by MarketBeat.com Staff